Institutions / Tpg Gp a, LLC
Tpg Gp a, LLC
CIK 1903793 · Institutionalso an insider · as of Dec 31, 2025
Portfolio value
$2.69B
Positions
10
As of
Dec 31, 2025
Top holdings
Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| LifeStance Health Group, Inc.LFST | $1.13B | 42.1% |
| Life Time Group Holdings, Inc. | $473.94M | 17.6% |
| BETA Technologies, Inc.BETA | $462.52M | 17.2% |
| Sionna Therapeutics, Inc. | $277.49M | 10.3% |
| Amneal Pharmaceuticals, Inc. | $155.34M | 5.8% |
| Ceribell, Inc.CBLL | $87.01M | 3.2% |
| Bicara Therapeutics Inc. | $50.67M | 1.9% |
| Allogene Therapeutics, Inc. | $25.64M | 1.0% |
| TPG RE Finance Trust, Inc. | $20.60M | 0.8% |
| Rallybio Corp | $2.09M | 0.1% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.
Insider transactions
Also files Forms 3 / 4 / 5
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| May 12, 2026 | Sell | LFST LifeStance Health Group, Inc. Common Stock | $226.82M | -28.3M -20.20% | 111,744,614 29.25% of shares | high |
| Mar 2, 2026 | Sell | LFST LifeStance Health Group, Inc. Common Stock | $145.00M | -20.7M -12.87% | 140,026,557 36.65% of shares | high |
| May 11, 2026 | Buy | ODTX Odyssey Therapeutics, Inc. Common Stock | $25.00M | +1.4M +60.35% | 3,690,146 7.68% of shares | high |
| Jan 22, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $10.00M | -250K -3.71% | 6,494,962 14.37% of shares | medium |
| Jan 29, 2026 | Buy | TPG Twin Brook Capital Income Fund Common shares of beneficial interest, Class I | $10.00M | +397K +2.37% | 17,175,144 15.66% of shares | high |
| Jun 26, 2026 | Sell | CBLL Ceribell, Inc. Common Stock | $4.07M | -202K -5.10% | 3,765,054 9.81% of shares | medium |
| May 11, 2026 | Other | ODTX Odyssey Therapeutics, Inc. Common Stock | $42.3K | -2K -0.56% | 420,760 0.88% of shares | low |
| May 11, 2026 | Other | ODTX Odyssey Therapeutics, Inc. Series D Preferred Stock | — | -18.3M -100.00% | 0 0.00% of shares | low |
| May 11, 2026 | Other | ODTX Odyssey Therapeutics, Inc. Warrants (right to buy) | — | -423K -100.00% | 0 0.00% of shares | low |
| May 11, 2026 | Other | ODTX Odyssey Therapeutics, Inc. Common Stock | — | +1.9M +446.93% | 2,301,257 4.79% of shares | low |